These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8243628)

  • 21. Molecular mechanism of diltiazem interaction with L-type Ca2+ channels.
    Kraus RL; Hering S; Grabner M; Ostler D; Striessnig J
    J Biol Chem; 1998 Oct; 273(42):27205-12. PubMed ID: 9765241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
    Balwierczak JL; Johnson CL; Schwartz A
    Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of 1,4-dihydropyridine binding domains within the primary structure of the alpha 1 subunit of the skeletal muscle L-type calcium channel.
    Kalasz H; Watanabe T; Yabana H; Itagaki K; Naito K; Nakayama H; Schwartz A; Vaghy PL
    FEBS Lett; 1993 Sep; 331(1-2):177-81. PubMed ID: 8405401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of four diltiazem stereoisomers on binding of d-cis-[3H]diltiazem and (+)-[3H]PN200-110 to rabbit T-tubule calcium channels.
    Ikeda S; Oka J; Nagao T
    Eur J Pharmacol; 1991 Nov; 208(3):199-205. PubMed ID: 1663043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules.
    Kirley TL; Schwartz A
    Biochem Biophys Res Commun; 1984 Aug; 123(1):41-9. PubMed ID: 6089800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calciseptine binding to a 1,4-dihydropyridine recognition site of the L-type calcium channel of rat synaptosomal membranes.
    Yasuda O; Morimoto S; Chen Y; Jiang B; Kimura T; Sakakibara S; Koh E; Fukuo K; Kitano S; Ogihara T
    Biochem Biophys Res Commun; 1993 Jul; 194(2):587-94. PubMed ID: 8393668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization.
    Zobrist RH; Mecca TE
    J Pharmacol Exp Ther; 1990 May; 253(2):461-5. PubMed ID: 2338642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The purified Ca2+ antagonist receptor from skeletal muscle: subunit structure, photoaffinity labeling and endogenous protein kinase activity.
    Tuana BS; Murphy BJ; Yi Q
    Mol Cell Biochem; 1988; 80(1-2):133-43. PubMed ID: 2845255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular studies of the calcium antagonist binding site on calcium channels.
    Schwartz A
    Am J Cardiol; 1994 Mar; 73(6):12B-14B. PubMed ID: 8141073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The failure of endothelin to displace bound, radioactively-labelled, calcium antagonists (PN 200/110, D888 and diltiazem).
    Gu XH; Liu JJ; Dillon JS; Nayler WG
    Br J Pharmacol; 1989 Feb; 96(2):262-4. PubMed ID: 2538185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.
    Striessnig J; Knaus HG; Glossmann H
    Biochem J; 1988 Jul; 253(1):39-47. PubMed ID: 2844171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
    Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P
    Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
    Kanngiesser U; Pongs O
    Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium-channel alpha 1 subunit.
    Regulla S; Schneider T; Nastainczyk W; Meyer HE; Hofmann F
    EMBO J; 1991 Jan; 10(1):45-9. PubMed ID: 1846597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photochemical localization of the semotiadil binding region within the cardiac Ca2+ channel alpha1 subunit. Comparison with the skeletal muscle counterpart.
    Ii N; Kuniyasu A; Kawahara K; Shibano T; Schwartz A; Nakayama H
    FEBS Lett; 1998 Dec; 441(1):83-7. PubMed ID: 9877170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
    Homaidan FR; Donowitz M; Weiland GA; Sharp GW
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
    Galizzi JP; Fosset M; Lazdunski M
    Biochem Biophys Res Commun; 1985 Oct; 132(1):49-55. PubMed ID: 2998366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates.
    Galizzi JP; Fosset M; Lazdunski M
    Eur J Biochem; 1984 Oct; 144(2):211-5. PubMed ID: 6092067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
    Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
    Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.